AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
218.04
-10.16 (-4.45%)
At close: Oct 31, 2025, 4:00 PM EDT
217.80
-0.24 (-0.11%)
After-hours: Oct 31, 2025, 7:58 PM EDT
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,084,436
Profits / Employee
$42,691
Market Cap
385.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABBV News
- 16 hours ago - AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 20 hours ago - AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend - Benzinga
- 21 hours ago - AbbVie: Why Q3 Confirms Its Immunology Dominance - Seeking Alpha
- 23 hours ago - AbbVie Lifts Profit Outlook as Sales Rise - WSJ
- 1 day ago - AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings. - Barrons
- 1 day ago - AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs - Reuters
- 1 day ago - AbbVie Reports Third-Quarter 2025 Financial Results - PRNewsWire
- 2 days ago - The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year - PRNewsWire